Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
- PMID: 20378577
- PMCID: PMC2857189
- DOI: 10.3324/haematol.2009.012864
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
Abstract
Background: Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described.
Design and methods: Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival.
Results: Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values.
Conclusions: This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.
Figures



Similar articles
-
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.Am J Clin Pathol. 2013 Feb;139(2):242-54. doi: 10.1309/AJCP2Z0TAGMUYJEB. Am J Clin Pathol. 2013. PMID: 23355209 Free PMC article.
-
[Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].Zhonghua Bing Li Xue Za Zhi. 2018 Jan 8;47(1):32-38. doi: 10.3760/cma.j.issn.0529-5807.2018.01.007. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29325248 Chinese.
-
[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24314242 Chinese.
-
The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.Acta Haematol. 2020;143(6):520-528. doi: 10.1159/000505892. Epub 2020 Feb 19. Acta Haematol. 2020. PMID: 32074595 Review.
-
[Significance and application of c-myc in diffuse large B-cell lymphoma].Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):638-40. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24314257 Review. Chinese. No abstract available.
Cited by
-
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.Cancer Res. 2020 Jun 15;80(12):2498-2511. doi: 10.1158/0008-5472.CAN-19-2247. Epub 2020 Apr 29. Cancer Res. 2020. PMID: 32350066 Free PMC article.
-
Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma.Sci Rep. 2018 Jul 12;8(1):10590. doi: 10.1038/s41598-018-28619-z. Sci Rep. 2018. PMID: 30002430 Free PMC article.
-
Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.PLoS One. 2017 Feb 17;12(2):e0172364. doi: 10.1371/journal.pone.0172364. eCollection 2017. PLoS One. 2017. PMID: 28212447 Free PMC article.
-
[Prognostic analysis of BCL-2/MYC double- hit in diffuse large B-cell lymphoma].Zhonghua Xue Ye Xue Za Zhi. 2015 Aug;36(8):656-61. doi: 10.3760/cma.j.issn.0253-2727.2015.08.006. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26462634 Free PMC article. Chinese.
-
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.Br J Haematol. 2016 Nov;175(4):631-640. doi: 10.1111/bjh.14282. Epub 2016 Jul 29. Br J Haematol. 2016. PMID: 27469075 Free PMC article.
References
-
- Stein H, Warnke RA, Chan WC, Jaffe ES, Chan JKC, Gatter KC, et al. Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008. pp. 233–7.
-
- Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937–47. - PubMed
-
- Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350(18):1828–37. - PubMed
-
- Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8(1):68–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources